Improving quality of life in patients with CHD and CHF: Focusing on mildronate-Reference-Cited by-同舟云学术

Improving quality of life in patients with CHD and CHF: Focusing on mildronate

Published:2023-11-11 Issue:25 Volume: Page:21-25
ISSN:2949-2807
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Teplova N. V.¹^ORCID,Vardanyan A. G.¹,Grigoryan V. O.²^ORCID

Affiliation:

1. Department of Clinical Pharmacology of Faculty of Medicine of Russian National Research Medical University n.a. N.I. Pirogov

2. City Clinical Hospital No. 15 n.a. O.M. Filatov

Abstract

This article describes clinical cases of patients with ischemic heart disease complicated by severe chronic heart failure during basic therapy with the inclusion of Mildronate. The results of the treatment prove the effectiveness of the use of this drug, in the form of an increase in exercise tolerance, regression of CHF phenomena, and improvement in the quality of life of patients with a burdened cardiovascular history.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference29 articles.

1. Healthcare in Russia. 2021: Stat. Sat. Rosstat. M., 171 pp., Federal State Statistics Service: [Electronic resource]. URL: https://rosstat.gov.ru/folder/12781. (Date of access – 07/22/22).

2. Putilina M.V. Combined neuroprotective therapy in cerebrovascular diseases cerebrovascular diseases. Physician; 2012, 4: 69–73.

3. Metelskaya V.A., Oganov R.G., Evsikov E.M., Teplova N.V. Relationship between the level of nitric oxide in peripheral blood serum and the nature of the pathology of the cardiovascular system and internal organs in patients with primary arterial hypertension. Russian Journal of Cardiology; 2011: V. 16 (4): 23–31.

4. O.A. Goroshko, V.G. Kukes, A.B. Prokofiev, V.V. Arkhipov, and E. Yu. Demchenkova. Clinical and pharmacological aspects of the use of antioxidant drugs. International Journal of Applied and Basic Research; 2016, 4–5: 905–912; URL: https://applied-research.ru/ru/article/view?id=9101 (date of access: 07/03/2022).

5. Potupchik. Т. Possibilities of using the drug Meldonium Organica in complex therapy of cardiovascular and cerebrovascular pathology, T. Potupchik, L. Evert, O. Averyanova [et al.]. Phys. 2019. Т. 30. No. 9. P. 35–41.